Inventor · disambiguated record
Huaizhong Hu
Also filed as: HU HUAIZHONG
13 granted patents·10 pending applications·163 citations·filing 1999–2020
90Inventor score
Files withRENOVAR INC13NEVILLE JR DAVID M2US HEALTH2BEIJING KONRUNS PHARMACEUTICAL CO LTD1CANBRIDGE LIFE SCIENCES LTD1
Top patents by PatentIndex Score
23 records- 0194US7696338B2Immunotoxin fusion proteins and means for expression thereofUS HEALTH·Filed 2001·Granted Apr 13, 2010·97 cites·2 claims
- 0292US7138230B2Systems and methods for characterizing kidney diseasesRENOVAR INC·Filed 2004·Granted Nov 21, 2006·43 cites·8 claims
- 0384US7476497B2Systems and methods for characterizing kidney diseasesRENOVAR INC·Filed 2006·Granted Jan 13, 2009·7 cites·10 claims
- 0478US8987426B2Immunotoxin fusion proteins and means for expression thereofNEVILLE JR DAVID M·Filed 2012·Granted Mar 24, 2015·2 cites·9 claims
- 0576US8217158B2Immunotoxin fusion proteins and means for expression thereofNEVILLE JR DAVID M·Filed 2010·Granted Jul 10, 2012·2 cites·4 claims
- 0666US7138229B2Systems and methods for characterizing kidney diseasesRENOVAR INC·Filed 2004·Granted Nov 21, 2006·7 cites·20 claims
- 0759US2009197287A1Systems and methods for characterizing kidney diseaseRENOVAR INC·Filed 2008·Application pending·0 cites
- 0858US2015011419A1Systems and methods for characterizing lupus erythematosusRENOVAR INC·Filed 2014·Application pending·0 cites
- 0958US2011236912A1Systems and methods for characterizing lupus erythematosusRENOVAR INC·Filed 2009·Application pending·0 cites
- 1057US10060930B2Systems and methods for characterizing kidney diseasesRENOVAR INCORPORATED·Filed 2016·Granted Aug 28, 2018·0 cites·7 claims
- 1153US9229011B2Systems and methods for characterizing kidney diseasesHU HUAIZHONG·Filed 2012·Granted Jan 5, 2016·0 cites·5 claims
- 1253US7244555B2Systems and methods for identifying organ transplant riskRENOVAR INC·Filed 2002·Granted Jul 17, 2007·3 cites·22 claims
- 1351US2003185825A1Novel immunotoxins and methods of inducing immune toleranceFiled 2003·Application pending·0 cites
- 1446US2006084184A1Reagents for urine-based immunological assaysRENOVAR INC·Filed 2004·Application pending·0 cites
- 1546US2008206794A1Systems And Methods For Characterizing Contrast Induced-NephropathyRENOVAR INC·Filed 2007·Application pending·0 cites
- 1645US2007202085A1Systems and methods for monitoring immune responses and predicting outcomes in transplant recipientsRENOVAR INC·Filed 2007·Application pending·0 cites
- 1745US2007134728A1Systems and methods for characterizing conditions and diseases associated with organ transplantation and organ healthRENOVAR INC·Filed 2006·Application pending·0 cites
- 1844US2007092898A1Detection of multiple anti-viral antibodiesRENOVAR INC·Filed 2006·Application pending·0 cites
- 1941US7531301B2Systems and methods for identifying organ transplant riskRENOVAR·Filed 2007·Granted May 12, 2009·0 cites·4 claims
- 2040US11834716B2Method for predicting response of esophagus cancer to anti-ERBB3 antibody therapy, and kitCANBRIDGE LIFE SCIENCES LTD·Filed 2018·Granted Dec 5, 2023·0 cites·9 claims
- 2136US12291503B2Crystalline form of compound, method for preparing the same, pharmaceutical composition and useBEIJING KONRUNS PHARMACEUTICAL CO LTD·Filed 2020·Granted May 6, 2025·0 cites·15 claims
- 2235US2003228635A1Cell proliferation assays and methodsRENOVAR INC·Filed 2003·Application pending·0 cites
- 2333US7517527B2Immunotoxin with in vivo T cell suppressant activity and methods of useUS HEALTH·Filed 1999·Granted Apr 14, 2009·2 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Huaizhong Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →